Carson Wealth (CWM LLC)
CYTK icon

Carson Wealth (CWM LLC)’s Cytokinetics CYTK Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.1K Buy
639
+159
+33% +$10.1K ﹤0.01% 3936
2025
Q4 		$30K Sell
480
-9
-2% -$560 ﹤0.01% 3947
2025
Q3 		$27K Buy
489
+37
+8% +$1.52K ﹤0.01% 3943
2025
Q2 		$15K Sell
452
-83
-16% -$2.89K ﹤0.01% 4073
2025
Q1 		$22K Sell
535
-444
-45% -$20.4K ﹤0.01% 3598
2024
Q4 		$46K Buy
979
+749
+326% +$38.9K ﹤0.01% 2862
2024
Q3 		$12K Buy
230
+51
+28% +$2.84K ﹤0.01% 3669
2024
Q2 		$10K Sell
179
-62
-26% -$3.74K ﹤0.01% 3531
2024
Q1 		$17K Sell
241
-144
-37% -$11.1K ﹤0.01% 3002
2023
Q4 		$32K Sell
385
-31
-7% -$1.12K ﹤0.01% 2464
2023
Q3 		$12K Sell
416
-50
-11% -$1.67K ﹤0.01% 3028
2023
Q2 		$15K Sell
466
-8
-2% -$296 ﹤0.01% 2806
2023
Q1 		$17K Buy
474
+24
+5% +$979 ﹤0.01% 2608
2022
Q4 		$21K Sell
450
-88
-16% -$3.79K ﹤0.01% 2323
2022
Q3 		$26K Buy
538
+245
+84% +$11.8K ﹤0.01% 2048
2022
Q2 		$12K Sell
293
-39
-12% -$1.57K ﹤0.01% 2456
2022
Q1 		$12K Buy
332
+4
+1% +$142 ﹤0.01% 2363
2021
Q4 		$15K Buy
+328
New +$12.7K ﹤0.01% 2132

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carson Wealth (CWM LLC)'s CYTK Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Cytokinetics (CYTK) stake by 33% in Q1 2026, buying an estimated $10.1K and bringing the position to 639 shares worth $42.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3936.

Carson Wealth (CWM LLC) first reported a position in CYTK in Q4 2021 and has held it in 18 quarters since. The position peaked at $46K in Q4 2024. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Carson Wealth (CWM LLC) held 639 shares of Cytokinetics worth $42.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 159 Cytokinetics shares in Q1 2026, an estimated $10.1K.
  • Cytokinetics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3936 holding.
  • Carson Wealth (CWM LLC) first reported a position in Cytokinetics in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Cytokinetics position peaked at $46K in Q4 2024.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.